These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 25054634

  • 1. Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.
    Hajak G, Lemme K, Zisapel N.
    Int Clin Psychopharmacol; 2015 Jan; 30(1):36-42. PubMed ID: 25054634
    [Abstract] [Full Text] [Related]

  • 2. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

  • 3. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 4. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N.
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [Abstract] [Full Text] [Related]

  • 5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 6. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P, Nir T, Laudon M, Zisapel N.
    J Sleep Res; 2007 Dec 16; 16(4):372-80. PubMed ID: 18036082
    [Abstract] [Full Text] [Related]

  • 7. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z.
    Arch Womens Ment Health; 2011 Jun 16; 14(3):269-73. PubMed ID: 21311927
    [Abstract] [Full Text] [Related]

  • 8. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep 16; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 9. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
    Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.
    Clin Interv Aging; 2014 Sep 16; 9():947-61. PubMed ID: 24971004
    [Abstract] [Full Text] [Related]

  • 10. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.
    Lemoine P, Zisapel N.
    Expert Opin Pharmacother; 2012 Apr 16; 13(6):895-905. PubMed ID: 22429105
    [Abstract] [Full Text] [Related]

  • 11. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA.
    Drugs Aging; 2012 Nov 16; 29(11):911-23. PubMed ID: 23044640
    [Abstract] [Full Text] [Related]

  • 12. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb 16; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 16; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct 16; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 15. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul 16; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 16. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC, Mungiu OC.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jul 16; 116(3):862-6. PubMed ID: 23272543
    [Abstract] [Full Text] [Related]

  • 17. A postmarketing surveillance study of zopiclone in insomnia.
    Mahendran R, Chee KT, Peh LH, Wong KE, Lim L.
    Singapore Med J; 1994 Aug 16; 35(4):390-3. PubMed ID: 7899899
    [Abstract] [Full Text] [Related]

  • 18. Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
    Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N.
    Ther Clin Risk Manag; 2011 Aug 16; 7():301-11. PubMed ID: 21845053
    [Abstract] [Full Text] [Related]

  • 19. The use of prolonged-release melatonin in circadian medicine: a systematic review.
    Del Casale A, Arena JF, Giannetti F, Minervino A, Biggio G, Girardi P.
    Minerva Med; 2024 Apr 16; 115(2):125-142. PubMed ID: 38713204
    [Abstract] [Full Text] [Related]

  • 20. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B, Anderer P, Brandstätter N, Frey R, Grünberger J, Klösch G, Mandl M, Wetter T, Zeitlhofer J.
    Neuropsychobiology; 1994 Apr 16; 29(2):69-90. PubMed ID: 8170529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.